The Promise of Artificial Intelligence in Reshaping Anticancer Drug Development

Kostas A. Papavassiliou; Amalia A. Sofianidi; Vassiliki A. Gogou; Athanasios G. Papavassiliou

doi:10.3390/cells13201709

Cells (Oct 2024)

The Promise of Artificial Intelligence in Reshaping Anticancer Drug Development

Kostas A. Papavassiliou,
Amalia A. Sofianidi,
Vassiliki A. Gogou,
Athanasios G. Papavassiliou

Affiliations

Kostas A. Papavassiliou: First University Department of Respiratory Medicine, Medical School, ‘Sotiria’ Hospital, National and Kapodistrian University of Athens, 11527 Athens, Greece
Amalia A. Sofianidi: Department of Biological Chemistry, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece
Vassiliki A. Gogou: First University Department of Respiratory Medicine, Medical School, ‘Sotiria’ Hospital, National and Kapodistrian University of Athens, 11527 Athens, Greece
Athanasios G. Papavassiliou: Department of Biological Chemistry, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece

DOI: https://doi.org/10.3390/cells13201709
Journal volume & issue: Vol. 13, no. 20
p. 1709

Abstract

Read online

While the concept of artificial intelligence (AI) has deep historical roots, its development as a formal scientific field was initiated in the 1950s by Newell and Simon, who invented a “thinking machine” called the Logic Theorist [...]

n/a

Published in Cells

ISSN: 2073-4409 (Online)
Publisher: MDPI AG
Country of publisher: Switzerland
LCC subjects: Science: Biology (General): Cytology
Website: https://www.mdpi.com/journal/cells

About the journal

Abstract

Keywords